The government-run All India Institute of Medical Sciences in Bhopal has been conducting drug trials for the treatment of coronavirus that yielded some good results, a senior official claimed on Saturday.
The trials of the drug Mycobacterium W were conducted on Covid-19 patients at AIIMS Bhopal. The trials were being run for the last few days and the results were good, as out of four patients enrolled for the trial, three had fully recovered and discharged, the director of the institute Dr. Sarman Singh told PTI.
If Mycobacterium W proves effective during the clinical trial, it will be used in the treatment of Covid-19, he said. Mycobacterium W was used in the treatment of leprosy and recently, the Council for Scientific and Industrial Research tied up with Cadila Pharmaceuticals Ltd. to evaluate the effect of this medicine for faster recovery of hospitalised Covid-19 patients, Singh said.
The Drug Controller of India has granted permission to conduct tests on critically ill Covid-19 patients at three major hospitals in the country, including AIIMS Bhopal.
Singh also informed that soon Favipiravir, a drug used in Japan, will also be used for Covid-19 treatment.
(Source: PTI)